UB Paderborn / Katalog / Suche / in CDI

Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again

American journal of transplantation, 2020-01, Vol.20 (1), p.204-212

2020

Link zum Volltext

Verfügbarkeit prüfen

Response to “Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again”

American journal of transplantation, 2020-02, Vol.20 (2), p.615-616

2020

Link zum Volltext

Verfügbarkeit prüfen

Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer

Annals of surgical oncology, 2022-05, Vol.29 (5), p.3361-3362

2022

Link zum Volltext

Verfügbarkeit prüfen

ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy

Annals of surgical oncology, 2022-04, Vol.29 (4), p.2626-2627

2022

Link zum Volltext

Verfügbarkeit prüfen

Standardizing Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Treatment: Navigating Complexities and Charting the Path Forward

Cancers, 2024-01, Vol.16 (2), p.400

2024

Link zum Volltext

Verfügbarkeit prüfen

Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer

Annals of surgical oncology, 2014-07, Vol.21 (7), p.2383-2389

2014

Link zum Volltext

Verfügbarkeit prüfen

Validation of a peritoneal surface disease severity score in stage IIIC-IV ovarian cancer treated with cytoreduction and hyperthermic intraperitoneal chemotherapy

Surgical oncology, 2019-03, Vol.28, p.57-61

2019

Link zum Volltext

Verfügbarkeit prüfen

Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin

Annals of surgery, 2018-11, Vol.268 (5), p.845-853

2018

Link zum Volltext

Verfügbarkeit prüfen

ASO Visual Abstract: Cytoreductive Surgery with or Without HIPEC after Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase III Clinical Trial

Annals of surgical oncology, 2022-04, Vol.29 (4), p.2628-2629

2022

Link zum Volltext

Verfügbarkeit prüfen

The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction

Annals of surgical oncology, 2015-03, Vol.22 (3), p.987-993

2015

Link zum Volltext

Verfügbarkeit prüfen

RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer

Clinical & experimental metastasis, 2021-04, Vol.38 (2), p.255-255

2021

Link zum Volltext

Verfügbarkeit prüfen

Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used

Langenbeck's archives of surgery, 2021-11, Vol.406 (7), p.2449-2456

2021

Link zum Volltext

Verfügbarkeit prüfen

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

World journal of surgical oncology, 2020-05, Vol.18 (1), p.92-92, Article 92

2020

Link zum Volltext

Verfügbarkeit prüfen

Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?

Surgical oncology, 2020-06, Vol.33, p.19-23

2020

Link zum Volltext

Verfügbarkeit prüfen

Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma

Scientific reports, 2023-04, Vol.13 (1), p.5621-5621, Article 5621

2023

Link zum Volltext

Verfügbarkeit prüfen

Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis

Cancers, 2023-04, Vol.15 (7), p.2122

2023

Link zum Volltext

Verfügbarkeit prüfen

Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC

Clinical & experimental metastasis, 2019-10, Vol.36 (5), p.433-439

2019

Link zum Volltext

Verfügbarkeit prüfen

Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports

World journal of hepatology, 2020-10, Vol.12 (10), p.870-879

2020

Link zum Volltext

Verfügbarkeit prüfen

HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey

Cancers, 2023-07, Vol.15 (13), p.3481

2023

Link zum Volltext

Verfügbarkeit prüfen

POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LIVER TRANSPLANTATION. USEFUL, NECESSARY OR IRRELEVANT?

European journal of radiology, 2017-06, Vol.91, p.155-159

2017

Link zum Volltext

Verfügbarkeit prüfen

Tres semanas de docencia virtual en la Universidad de Murcia (II): Fisioterapia, Odontología, Cirugía y Fisiología

Revista española de educación médica, 2020-05, Vol.1 (1), p.47-54

2020

Link zum Volltext

Verfügbarkeit prüfen

Indication for liver transplantation in a patient with a history of a gastric lymphoma

Revista española de enfermedades digestivas, 2016-06, Vol.108 (6), p.379-379

2016

Link zum Volltext

Verfügbarkeit prüfen

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Case Reports in Medicine, 2013-01, Vol.2013, p.283295-3

2013

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again

Response to “Controlled donation after circulatory death up to 80 years for liver transplantation: Pushing the limit again”

Post-Publication Discussion Regarding Cytoreductive Surgery with or Without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer

ASO Author Reflections: HIPEC with Cisplatin Improves Prognosis in Advanced Ovarian Cancer after Neoadjuvant Chemotherapy

Standardizing Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer Treatment: Navigating Complexities and Charting the Path Forward

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP)

Treatment of Microscopic Disease with Hyperthermic Intraoperative Intraperitoneal Chemotherapy After Complete Cytoreduction Improves Disease-Free Survival in Patients with Stage IIIC/IV Ovarian Cancer

Validation of a peritoneal surface disease severity score in stage IIIC-IV ovarian cancer treated with cytoreduction and hyperthermic intraperitoneal chemotherapy

Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin

ASO Visual Abstract: Cytoreductive Surgery with or Without HIPEC after Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase III Clinical Trial

The Role of Hyperthermic Intraperitoneal Chemotherapy Using Paclitaxel in Platinum-Sensitive Recurrent Epithelial Ovarian Cancer Patients with Microscopic Residual Disease after Cytoreduction

RETRACTED ARTICLE: Upfront citorreduction and hyperthermic intraperitoneal chemotherapy with paclitaxel in patients with stage III-C serous epithelial ovarian cancer

Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease

Intraperitoneal hyperthermic chemotherapy after cytoreduction in patients with peritoneal metastases from endometrial cancer. The next frontier?

Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma

Selecting the Appropriate Downstaging and Bridging Therapies for Hepatocellular Carcinoma: What Is the Role of Transarterial Radioembolization? A Pooled Analysis

Peritoneal Surface Disease Severity Score (PSDSS), AGO-score and TIAN model in patients with platinum-sensitive recurrent ovarian cancer treated by cytoreductive surgery plus HIPEC

Severe COVID-19 after liver transplantation, surviving the pitfalls of learning on-the-go: Three case reports

HIPEC in Ovarian Cancer Is the Future… and Always Will Be? Results from a Spanish Multicentric Survey

POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA UNDERGOING LIVER TRANSPLANTATION. USEFUL, NECESSARY OR IRRELEVANT?

Treatment of Peritoneal Surface Malignancies by Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Spain: Results of the National Registry of the Spanish Group of Peritoneal Oncologic Surgery (REGECOP)

Tres semanas de docencia virtual en la Universidad de Murcia (II): Fisioterapia, Odontología, Cirugía y Fisiología

Indication for liver transplantation in a patient with a history of a gastric lymphoma

Peritoneal Dissemination of Hepatoid Carcinoma of the Ovary Treated with Cytoreductive Surgery and Hyperthermic Intraoperative Intraperitoneal Chemotherapy

Suchergebnisse filtern